DS-6930 [CAS 1242328-82-0]

DS-6930 is a potent and selective agonist of PPARγ, with an EC50 of 41 nM. DS-6930 could robust reduce plasma glucose (PG), and with fewer PPARγ-related adverse effects than Rosiglitazone. DS-6930 can be used for the research of diabetes[1].

[1242328-82-0]

C23H21N3O4

403.43

O=C(O)C1=CC=CC(OCC2=NC3=CC=C(OC4=NC=C(C)C=C4C)C=C3N2C)=C1

PPAR

PPARγ

10 mM in DMSO

Room temperature